Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

Researchers have uncovered a new understanding of levodopa-induced dyskinesia, a common side effect in Parkinson’s patients, ...

University of Arizona researchers revealed that dyskinesia in Parkinson’s patients stems from a disconnect in the motor ...

Levodopa is the most efficacious agent for the treatment of motor features of Parkinson's disease but its chronic use is associated with the development of motor complications. Mounting evidence ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's ...

University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson's ...

Parkinson's patients who experience uncontrollable spasms could be treated with a course of ketamine, researchers have found ...

Rodent study indicates that the motor cortex becomes disconnected during episodes of involuntary and uncontrollable movements ...

Researchers at the University of Arizona have shed light on a common and troubling side effect of long-term Parkinson’s ...

Berlin, Germany, and Research Triangle Park, N.C., USA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaEnrollment ongoing in the ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's drug levodopa. University of Arizona researchers have revealed new ...